Purchase of contrast materials in 12 parts for the National Institute of Oncology as follows: Part 1: purchase of contrast agents sodium amidotrizoate and meglumine amidotrizoate (ATC code: V08AA01), containing 10,000+66,000 active substances (100 mg/ml+660 mg/ml) in 150 doses Part 2: Acquisition of ioxytalamate meglumine contrast agent (ATC code: V08AA05), 66.03 (0.6603g/ml) active substance, 2760 pcs Part 3: procurement of a contrast agent containing gadoteridol (ATC code: V08CA04), containing 10 (0.5 mmol/ml) active substances in 100 doses Part 4: Acquisition of contrast agents containing iopromide (a) ATC code: V08AB05 containing 37 000 (370 mg I/ml) active substances in 300 quantities (b) ATC code: V08AB05 containing 185,000 (370 mg I/ml) active substances in 344 doses Part 5: Acquisition of a contrast agent containing the active substance Iomeprol (a) ATC code: V08AB10, containing 15,000 (300 mg I/ml) active substances in 250 quantities (b) ATC code: V08AB10, containing 17 500 active substances (350 mg I/ml) in quantities of 200 c.) ATC code: V08AB10, containing 70,000 (350 mg I/ml) active substances in 360 doses (d) ATC code: V08AB10 containing 175,000 (350 mg I/ml) active substances in 2,600 doses Part 6: Acquisition of a contrast agent containing the active substance iobitridol (a) ATC code: V08AB11, containing 70,000 (350 mg I/ml) active substances in 20 quantities (b) ATC code: V08AB11 containing 175,000 (350 mg I/ml) active substances in 40 doses Part 7: Acquisition of contrast agent iodine, ATC code: V08AD01 containing 4 800 (480 mg I/ml) active substances in 20 quantities Part 8: Acquisition of a contrast agent containing gadoteric acid (a) ATC code: V08CA02, containing 10 (0.5 mmol/ml) active substances in 60 quantities (b) ATC code: V08CA02 containing 30 (0.5 mmol/ml) active ingredients in 180 doses Part 9: purchase of gadobenate dimeglumine contrast agent, ATC code: V08CA08, 10 (0.5 mmol/ml), 620 pcs in quantity Part 10: Acquisition of a contrast agent containing the active substance gadobutrol (a) ATC code: V08CA08, containing 15 (1mmol/ml) active substances in a quantity of 300 (b) ATC code: V08CA08 containing 30 (1mmol/ml) active ingredients in 700 doses Part 11: purchase of a contrast agent containing sulfur hexafluoride, ATC code: V08DA05, containing 8 active substances in 84 quantities Part 12: Acquisition of contrast agent iopamidol (a) ATC code: V08AB04, containing 37 000 (370 mg I/ml) active substances in quantities of 100 (b) ATC code: V08AB04, containing 185,000 (370 mg I/ml) active ingredients, in the amount of 75 pieces Offer can only be made for the full amount. In the case of products where the contracting authority refers to a specific make/type, the offer of an equivalent product is also accepted on the basis of Section 46(3) of Government Decree No 321/2015. In this case, the burden of proof of equivalence shall be on the tenderer. Only new products that have not been used before can be offered. The contracting authority undertakes to order at least 70% of the total quantity for the duration of the contract. The detailed technical requirements are set out in the Tender Specifications.
Text automatically translated in your browsing language
Automatically translated
